Orchard Therapeutics

+$0.11 (+3.94%) Today
+$0.03 (+1.03%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ORTX and other ETFs, options, and stocks.

About ORTX

Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies.

CEO
Bobby Gaspar
Employees
224
Headquarters
London, Greater London
Founded
2018

ORTX Key Statistics

Market Cap
653.63M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
834.36K
High Today
$3.10
Low Today
$2.79
Open Price
$2.80
Volume
1.02M
52 Week High
$9.08
52 Week Low
$2.79

ORTX Earnings

-$0.51
-$0.34
-$0.17
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure